An investigational drug developed using generative artificial intelligence demonstrated tumor-shrinking activity in patients with heavily pretreated mesothelioma, offering another encouraging development in the search for new treatment options. A new investigational treatment for mesothelioma is showing promising early results in a Phase 1 clinical trial. Insilico Medicine announced that its experimental…